Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope

Yuzaiful Md Yusof,Eve M D Smith,Sammy Ainsworth,Kate Armon,Michael W Beresford,Morgan Brown,Lindsey Cherry,Christopher J Edwards,Kalveer Flora,Rebecca Gilman,Bridget Griffiths,Caroline Gordon,Paul Howard,David Isenberg,Natasha Jordan,Arvind Kaul,Peter Lanyon,Philip M Laws,Liz Lightsone,Hanna Lythgoe,Christian D Mallen,Stephen D Marks,Naomi Maxwell,Elena Moraitis,Clare Nash,Ruth J Pepper,Clarissa Pilkington,Antonios Psarras,Heather Rostron,Jade Skeates,Sarah Skeoch,Dalila Tremarias,Chris Wincup,Asad Zoma,Edward M Vital,Md Yuzaiful Md Yusof

DOI: https://doi.org/10.1093/rap/rkad093

2023-01-01

Rheumatology Advances in Practice

Abstract:Abstract The objective of this guideline is to provide up-to-date, evidence-based recommendations for the management of SLE that builds upon the existing treatment guideline for adults living with SLE published in 2017. This will incorporate advances in the assessment, diagnosis, monitoring, non-pharmacological and pharmacological management of SLE. General approaches to management as well as organ-specific treatment, including lupus nephritis and cutaneous lupus, will be covered. This will be the first guideline in SLE using a whole life course approach from childhood through adolescence and adulthood. The guideline will be developed with people with SLE as an important target audience in addition to healthcare professionals. It will include guidance related to emerging approved therapies and account for National Institute for Health and Care Excellence Technology Appraisals, National Health Service England clinical commissioning policies and national guidance relevant to SLE. The guideline will be developed using the methods and rigorous processes outlined in ‘Creating Clinical Guidelines: Our Protocol’ by the British Society for Rheumatology.